Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;27(4):541-5.
doi: 10.1007/s00345-008-0370-0. Epub 2009 Jan 28.

Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate

Affiliations

Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate

T Bach et al. World J Urol. 2009 Aug.

Abstract

Purpose: Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.

Methods: VapoEnucleation was performed using a 70 W continuous wave-laser. After enucleation tissue was morcellated within the bladder. Prospectively assessed outcomes were improvement in urodynamic parameter and the intra- and postoperative course. Complications were recorded.

Results: A total of 88 consecutive patients with prostatic enlargement underwent VapoEnucleation. Prostatic volume was 61.3 +/- 24.0 cc (30-160). OR-time was 72 min +/- 26.6 (35-144) and laser-time 32.4 +/- 10.1 min (16.3-59.3). Applied laser energy was 123.7 +/- 40.6 kJ (67.8-240.9). An average of 31.7 +/- 18.3 g of tissue was retrieved. Pathology revealed four patients with incidental carcinoma. Foley catheter-time was 2 days and the suprapubic tube, if placed, was removed on the third postoperative day on average. Twelve complications were recorded, including bleeding (3), urinary tract infection (6), second-look procedure, due to insufficient deobstruction (2). Re-catherization after successful initial voiding trial was necessary in one patient. Mean peak flow rate improved from 3.5 +/- 4.7 to 19.8 +/- 11.6 ml/s and post-voiding residual urine decreased from 121.4 +/- 339.9 to 22.4 +/- 32.7 ml.

Conclusion: The functional outcomes demonstrate efficiency of Tm:YAG VapoEnucleation for patients with larger prostates. From our experience, learning curve in VapoEnucleation is short and complications are minimal. Theoretically, no limitation in prostate size occurs. Long-term follow-up is needed to prove durability.

PubMed Disclaimer

References

    1. Eur Urol. 2008 Apr;53(4):744-9 - PubMed
    1. J Endourol. 2004 Feb;18(1):109-12 - PubMed
    1. Eur Urol. 2006 Jan;49(1):87-91 - PubMed
    1. BJU Int. 2008 Jan;101(1):131-42 - PubMed
    1. Eur Urol. 2008 Feb;53(2):382-89 - PubMed

Publication types

LinkOut - more resources